Drug Shortage Report for TARO-SUMATRIPTAN

Last updated on 2018-06-18 History
Report ID 6953
Drug Identification Number 02361698
Brand name TARO-SUMATRIPTAN
Common or Proper name SUMATRIPTAN
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 6MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2x0.5mL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-23
Estimated end date 2018-06-07
Actual end date 2018-06-15
Shortage status Resolved
Updated date 2018-06-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2017-11-03 English Compare
v16 2017-09-21 French Compare
v15 2017-09-21 English Compare
v14 2017-08-02 French Compare
v13 2017-08-02 English Compare
v12 2017-07-21 French Compare
v11 2017-07-21 English Compare
v10 2017-07-07 French Compare
v9 2017-07-07 English Compare
v8 2017-05-30 French Compare
v7 2017-05-30 English Compare
v6 2017-05-13 French Compare
v5 2017-05-13 English Compare
v4 2017-04-18 English Compare
v3 2017-04-13 French Compare
v2 2017-04-13 English Compare
v1 2017-04-13 English Compare

Showing 21 to 37 of 37